Page last updated: 2024-09-03

rasagiline and Nerve Degeneration

rasagiline has been researched along with Nerve Degeneration in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (90.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biton, IE; Dror, V; Eliash, S; Rehavi, M1
Schapira, AH1
Cohen, S; Dror, V; Eliash, S; Rehavi, M1
Klivényi, P; Rákóczi, K; Vécsei, L1
Eilam, R; Eliash, S; Shteter, N1
Bhat, V; Weiner, WJ1
Amit, T; Mandel, S; Sagi, Y; Youdim, MB1
Blaugrund, E; Cohen, S; Fine, T; Litinetsky, L; Mayk, A; Nyska, A; Speiser, Z1
Akao, Y; Maruyama, W; Naoi, M; Yamaoka, Y; Yi, H1
Jankovic, J; Le, W; Li, J; Pan, T; Xie, W; Youdim, MB; Zhu, W1

Reviews

3 review(s) available for rasagiline and Nerve Degeneration

ArticleYear
Rasagiline in neurodegeneration.
    Experimental neurology, 2008, Volume: 212, Issue:2

    Topics: Animals; Humans; Indans; Nerve Degeneration; Neuroprotective Agents

2008
[Neuroprotection in Parkinson's disease and other neurodegenerative disorders: preclinical and clinical findings].
    Ideggyogyaszati szemle, 2009, Jan-30, Volume: 62, Issue:1-2

    Topics: Animals; Creatine; Dopamine Agonists; Glatiramer Acetate; Humans; Indans; Kynurenic Acid; Micronutrients; Nerve Degeneration; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Peptides; Selegiline; Tocopherols; Ubiquinone

2009
Parkinson's disease. Diagnosis and the initiation of therapy.
    Minerva medica, 2005, Volume: 96, Issue:3

    Topics: Antioxidants; Diagnosis, Differential; Dopamine Agonists; Humans; Hypokinesia; Indans; Levodopa; Muscle Rigidity; Nerve Degeneration; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Selegiline; Tremor

2005

Other Studies

7 other study(ies) available for rasagiline and Nerve Degeneration

ArticleYear
Rasagiline prevents neurodegeneration in thiamine deficient rats-a longitudinal MRI study.
    Brain research, 2014, Apr-04, Volume: 1557

    Topics: Animals; Brain; Diffusion Tensor Imaging; Disease Models, Animal; Disease Progression; Indans; Kaplan-Meier Estimate; Lateral Ventricles; Longitudinal Studies; Magnetic Resonance Imaging; Male; Monoamine Oxidase Inhibitors; Nerve Degeneration; Neuroprotective Agents; Organ Size; Pyrithiamine; Rats; Rats, Sprague-Dawley; Thalamus; Thiamine Deficiency

2014
Neuroprotection by rasagiline in thiamine deficient rats.
    Brain research, 2009, Feb-23, Volume: 1256

    Topics: Aging; Analysis of Variance; Animals; Behavior, Animal; Brain; Disease Models, Animal; Indans; Kaplan-Meier Estimate; Male; Maze Learning; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nerve Degeneration; Neuroprotective Agents; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Selegiline; Thiamine Deficiency

2009
Neuroprotective effect of rasagiline, a monoamine oxidase-B inhibitor, on spontaneous cell degeneration in a rat model.
    Journal of neural transmission (Vienna, Austria : 1996), 2005, Volume: 112, Issue:8

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Indans; Male; Monoamine Oxidase Inhibitors; Nerve Degeneration; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Paraventricular Hypothalamic Nucleus; Rats; Rats, Inbred SHR; Rats, Wistar; Third Ventricle; Treatment Outcome; Vasopressins

2005
Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism.
    Neurobiology of disease, 2007, Volume: 25, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Blotting, Western; Cell Survival; Cells, Cultured; DNA, Complementary; Dopamine; Dopamine Agents; Enzyme Activation; Gene Expression Regulation; Immunohistochemistry; Indans; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Nerve Degeneration; Nerve Tissue Proteins; Neuroprotective Agents; Parkinson Disease, Secondary; Receptor Protein-Tyrosine Kinases; Signal Transduction; Substantia Nigra

2007
Rasagiline is neuroprotective in an experimental model of brain ischemia in the rat.
    Journal of neural transmission (Vienna, Austria : 1996), 2007, Volume: 114, Issue:5

    Topics: Animals; Brain Infarction; Brain Ischemia; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Indans; Infarction, Middle Cerebral Artery; Male; Maze Learning; Nerve Degeneration; Neuroprotective Agents; Rats; Rats, Wistar; Recovery of Function; Time Factors; Treatment Outcome

2007
Involvement of type A monoamine oxidase in neurodegeneration: regulation of mitochondrial signaling leading to cell death or neuroprotection.
    Journal of neural transmission. Supplementum, 2006, Issue:71

    Topics: Cell Death; Cell Line, Tumor; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation; Humans; Indans; Mitochondria; Mitochondrial Membranes; Monoamine Oxidase; Nerve Degeneration; Neuroblastoma; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; Salsoline Alkaloids; Serotonin; Signal Transduction; Tetrahydroisoquinolines; Transfection

2006
Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration.
    Journal of neurochemistry, 2008, Volume: 105, Issue:5

    Topics: Acetylcysteine; Animals; Dopamine; Indans; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuroprotective Agents; Selegiline

2008